Abstract: A secondary battery case includes a recess part recessed downward, and a sealing part provided around the recess part when the secondary battery case is unfolded. At least portions of the sealing part are attached to each other to seal inner surfaces of the recess part from an outside. A secondary battery includes an electrode assembly and the secondary battery case. The recess part of the secondary battery case has a width that corresponds to a thickness of the electrode assembly.

Abstract: A secondary battery includes an electrode assembly having a positive electrode plate, a negative electrode plate, and a separator interposed between the positive and negative electrode plates, a can having at least one groove portion on an inner surface thereof, the electrode assembly being inserted into the can through an opening of the can to face the inner surface of the can, a cap assembly configured to seal the opening of the can, and an insulation case positioned in the can between the electrode assembly and the cap assembly, the insulation case including at least one protruding portion inserted into the groove portion of the can.

Abstract: A secondary battery including an electrode assembly, a can accommodating the electrode assembly, a cap assembly sealing the can, and an insulating case interposed between the electrode assembly and the cap assembly and having two facing long side walls and two facing short side walls, wherein the two facing long side walls include opposing end portions and opposing central portions, the opposing end portions and the opposing central portions each include outer surfaces and a distance between the outer surfaces of the opposing end portions of the long side walls is greater than a distance between the outer surfaces of the opposing central portions of the long side walls.

Abstract: The present invention relates to therapeutic and prophylactic methods for treating or preventing an infectious disease in a subject by stimulating or enhancing an immune response against an infectious agent causing the disease. The methods comprise administering to the subject a plurality of compositions, each composition being administered to a different site of the subject, wherein each site is, or substantially drains to, an anatomically distinct lymph node, a group of lymph nodes, a nonencapsulated cluster of lymphoid tissue, or the spleen. Each composition comprises at least one antigenic molecule having one or more epitopes of the same infectious agent or a strain thereof. The antigenic molecules of each composition comprise in aggregate a set of epitopes distinct from that of any other composition that is administered to the subject.

Abstract: The present invention relates to therapeutic and prophylactic methods for treating Or preventing an infectious disease in a subject by stimulating or enhancing an immune response against an infectious agent causing the disease. The methods comprise administering to the subject a plurality of compositions, each composition being administered to a different site Of the subject, wherein each site is, or substantially drains to, an anatomically distinct lymph node, a group of lymph nodes, a nonencapsulated cluster of lymphoid tissue, or the spleen. Each composition comprises at least one antigenic molecule having one or more epitopes of the same infectious agent or a strain thereof. The antigenic molecules of each composition comprise in aggregate a set of epitopes distinct from that of any other composition that is administered to the subject.

Abstract: The present invention relates to therapeutic and prophylactic methods for treating or preventing an infectious disease in a subject by stimulating or enhancing an immune response against an infectious agent causing the disease. The methods comprise administering to the subject a plurality of compositions, each composition being administered to a different site of the subject, wherein each site is, or substantially drains to, an anatomically distinct lymph node, a group of lymph nodes, a nonencapsulated cluster of lymphoid tissue, or the spleen. Each composition comprises at least one antigenic molecule having one or more epitopes of the same infectious agent or a strain thereof. The antigenic molecules of each composition comprise in aggregate a set of epitopes distinct from that of any other composition that is administered to the subject.

Abstract: A can and a lithium secondary battery using the same. Electrolyte slots having predetermined shapes are formed at inner surfaces of short-sidewalls and a bottom wall of the can, and serve as an electrolyte path or an electrolyte receiving space, thereby allowing the electrolyte to be easily introduced into the can even if a jellyroll-type electrode assembly has been accommodated in the can, and increasing an amount of the electrolyte contained in the can.

Abstract: A secondary battery includes an electrode assembly having a positive electrode plate, a negative electrode plate, and a separator interposed between the positive and negative electrode plates, a can having at least one groove portion on an inner surface thereof, the electrode assembly being inserted into the can through an opening of the can to face the inner surface of the can, a cap assembly configured to seal the opening of the can, and an insulation case positioned in the can between the electrode assembly and the cap assembly, the insulation case including at least one protruding portion inserted into the groove portion of the can.

Abstract: A secondary battery including an electrode assembly, a can accommodating the electrode assembly, a cap assembly sealing the can, and an insulating case interposed between the electrode assembly and the cap assembly and having two facing long side walls and two facing short side walls, wherein the two facing long side walls include opposing end portions and opposing central portions, the opposing end portions and the opposing central portions each include outer surfaces and a distance between the outer surfaces of the opposing end portions of the long side walls is greater than a distance between the outer surfaces of the opposing central portions of the long side walls.

Abstract: An electrode assembly and a lithium ion secondary battery using the same capable of preventing a short circuit from being created in an outer peripheral portion of the electrode assembly. Uncoated areas of positive and negative electrode plates and an active material layer in the inner and outer peripheral portions of the electrode assembly are optimally aligned such that the thickness of the electrode assembly is uniformly formed widthwise along the electrode assembly.

Abstract: The present invention relates to therapeutic and prophylactic methods for treating or preventing an infectious disease in a subject by stimulating or enhancing an immune response against an infectious agent causing the disease. The methods comprise administering to the subject a plurality of compositions, each composition being administered to a different site of the subject, wherein each site is, or substantially drains to, an anatomically distinct lymph node, a group of lymph nodes, a nonencapsulated cluster of lymphoid tissue, or the spleen. Each composition comprises at least one antigenic molecule having one or more epitopes of the same infectious agent or a strain thereof. The antigenic molecules of each composition comprise in aggregate a set of epitopes distinct from that of any other composition that is administered to the subject.

Abstract: An electrode assembly and a lithium ion secondary battery using the same capable of preventing a short circuit from being created in an outer peripheral portion of the electrode assembly. Uncoated areas of positive and negative electrode plates and an active material layer in the inner and outer peripheral portions of the electrode assembly are optimally aligned such that the thickness of the electrode assembly is uniformly formed widthwise along the electrode assembly.